Claris Ventures
Finance · Italy · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Turin, ItalyWebsite
www.clarisventures.comRevenue
<$5 MillionIndustry
About Claris Ventures
Is Claris Ventures your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Claris Ventures recently announced quarterly report
Check if Claris Ventures has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Claris Ventures has new funding data
Congratulate Masked Content for being promoted to Masked Content at Claris Ventures
Click to see if Claris Ventures had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Claris Ventures is spiking on competitors!
Product Launch: Get notified when Claris Ventures launches new products
Claris Ventures, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Claris Ventures
Find more new buyers
Claris Ventures Tech Stack
A closer look at the technologies used by Claris Ventures
Most Recent Scoops
Claris Ventures News & Media
Resalis Therapeutics Raises €10M in Series A Funding
Resalis Therapeutics, a Torino, Italy-based ncRNAs and RNA-targeted therapeutics company, raised €10M in Series A funding. The round was led by Sunstone Life Science Ventures with participation from existing investors including Claris Ventures and angel investors. In conjunction with the financing, Claus Andersson, PhD, General Partner of Sunstone Life Science Ventures, will join Resalis’ Board […] The post Resalis Therapeutics Raises €10M in Series A Funding appeared first on FinSMEs.NeoPhore completes extension to Series B financing to further advance discovery pipeline
Scientific milestones achieved significantly ahead of schedule CAMBRIDGE, England, Jan. 19, 2023 /PRNewswire/ -- NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announces the completion of its £21.5m (US $28.5m) Series B financing, with a £6m (US $7.5m)...Kither Biotech Raises €18.5M in Series B Funding
Kither Biotech, a Turin, Italy-based biopharmaceutical company developing novel therapies for rare respiratory diseases, raised €18.5m in Series B financing round. The round was co-led by new investors Claris Ventures and 2 Invest, with participation from 3B Future Health Fund and Alef 6 and existing investors CDP Venture Capital SGR, Italian Angels for Growth, Ersel, […] The post Kither Biotech Raises €18.5M in Series B Funding appeared first on FinSMEs.NeoPhore Announces £15.2m Financing to Advance DNA Mismatch Repair Pipeline
Round led by Claris Ventures with 2Invest, 3B Future Health Fund and Astellas Venture Management CAMBRIDGE, England, March 9, 2021 /PRNewswire/ -- NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announces the close of a £15.2m (US $21m) Series B round. The...
Top Finance Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Claris Ventures
Claris Ventures is a venture capital firm dedicated to supporting leading scientists in the life sciences sector, focusing on early-stage biopharma companies. The firm invests in innovative solutions addressing critical unmet clinical needs, including rare diseases, oncology, and immunology. Claris Ventures provides capital, expertise, and hands-on... Read More